We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Structural Analysis Explains LDL Receptor Function

By Biotechdaily staff writers
Posted on 18 Dec 2002
A study has revealed new information about the structure of the low-density lipoprotein (LDL) receptor and suggested a mechanism by which the receptor transfers LDL into the interior of the cell. More...
The study was published November 29, 2002, in the online edition of Science.

Previous work had shown that LDL receptors bind LDL on the cell surface under conditions of neutral pH. A process known as receptor-mediated endocytosis moves the receptor-LDL complex into the acidic environment of the endosomes. The LDL is released at pH 6 or lower, and the receptor returns to the outer surface of the plasma membrane to repeat the process.

The LDL receptor's extracellular domain consists of two major parts, the LDL binding region and the ‘beta-propeller' region. In the current study, researchers from the University of Texas Southwestern Medical Center (Dallas, USA) studied the structure of the LDL receptor under acidic conditions. They found that the LDL binding region attached to the ‘beta-propeller' region at low pH and thus could not bind to LDL. The ‘beta-propeller' acted as an alternate substrate for the ligand-binding domain, binding in a calcium dependent way and promoting lipoprotein release.

"This research will help scientists understand the mechanics of how our bodies absorb cholesterol from the blood,” explained senior author Dr. Jophann Deisenhofer, professor of biochemistry at UT Southwestern. "Hopefully, we can use the information to develop treatments for people with mutations that diminish the functions of their LDL receptors.”



Related Links:
Univ. of Texas Southwestern Medical Center

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.